BofA Raises Philip Morris International Price Target by 9 Analysts Eye SmokeFree Growth Berkshire Hathaway Rebuilds Airline Exposure with 26 Billion Delta Air Lines Stake Ella Langley Dominates Billboard Hot 100 Outpacing Ariana Grande and Mariah Careys SingleFrame Feats Bernstein Maintains Outperform Rating on UnitedHealth Amid PBM Transparency Developments Nvidia Reports Another Strong Quarter Revenue Surges 85 to 816 Billion in Fiscal Q1 Social Security at 62 vs Survivors Benefit at 67 A Retirement Planning Dilemma at 20000 Annual Income Commvault Systems CVLT Q1 2026 Earnings Strong EPS Beat Drives Mild Stock Uptick Oxford Industries Q1 2026 Earnings Earnings Miss Widens Despite Stock Rally KAPA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline CVR Partners UAN Q1 2026 Earnings Strong PerUnit Income Amid Steady Fertilizer Demand CTMX Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues CWAN Q1 2026 Earnings Slight EPS Miss Amid Steady Performance Redwood Trust Senior Notes RWTP Hover Near Flat as Market Digests Modest Yield Adjustments Community Trust Bancorp CTBI Slightly Lower as Shares Test Support Levels Abony Acquisition Corp I Units AACOU Holds Steady at 999 as Market Awaits Catalyst Preferred Bank PFBC Edges Higher Consolidation Near Key Resistance Lincoln Educational Services LINC Surges 33 as Shares Approach Key Resistance Zone Consumer Sentiment Sinks to Historic Low in May as Gas Prices Surge Amid Iran Conflict SLGL Q4 2025 Earnings EPS Misses Estimates as DevelopmentStage Biotech Reports No Revenue Tvardi Therapeutics TVRD Holds Steady Near Support Amid LowVolume Trading Datavault AI Inc DVLT Q1 2026 Earnings Widerthanexpected loss drags shares lower Uranium Royalty Corp UROY Q1 2026 Earnings EPS Turns Positive Topping Estimates by 199 Stock Slips 3 Golden Entertainment Inc GDEN Q4 2025 Earnings Significant EPS Miss Amid Flat Revenue Disclosure Kroger Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Beats Expectations Stock Edges Higher Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status OABI Q1 2026 Earnings WiderthanExpected Loss Narrows as EPS Surprises Positively